Generics Bulletin’s Top 50 Ranking For 2020

Compiling All The Data From Our List Of The Top Industry Players

This article brings you a compilation of all the data from Generics Bulletin's recent ranking of the top 50 generics and biosimilars companies, including additional details of how the financial figures stack up.

Top_50
The complete rundown of our Top 50 ranking • Source: Shutterstock

This week has seen Generics Bulletin publish its annual top 50 ranking of the leading companies in the off-patent sector.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Company Rankings

More from Market Intelligence

UK Gabapentin Prices Shoot Up In December

 
• By 

UK prices for gabapentin almost trebled in December, according to the latest figures from WaveData.

UK Memantine Prices Spike In November

 
• By 

Dementia treatment memantine saw the steepest rise in its UK trade price in November, according to the latest figures from WaveData.

Apixaban Prices Begin To Correct After Months Of UK Rises

 
• By 

After a few months of steep UK price rises for apixaban generics, October saw a correction as average prices headed in the opposite direction, the latest figures from WaveData reveal.